emergenresearch

  The global pharmacovigilance market is expected to be worth USD 12.48 Billion by 2027, according to a current analysis by Emergen Research. The market for pharmacovigilance is experiencing rapid growth attributed to a rise in application for spontaneous reporting, electronic health record (HER) mining, cohort event monitoring, and intensified adverse drug reaction (ADR) reporting, among others. The pharmacovigilance primarily emphasizes on on ADR (adverse drug reactions) and cases of drug toxicity. According to the statistic released by WHO, about 5.0% of hospitalized patients in the developed nations are admitted into the hospital due to adverse drug reactions, and 6.0% to 10% of in-patients are anticipated to observe a severe adverse reaction for the duration of hospitalization. The Global  Pharmacovigilance Market  report provides full coverage of the companies’ data, including details about their production and manufacturing capacity, product portfolio, business ove...

  The latest study on the Computerized Physician Order Entry CPOE Market industry includes a detailed analysis of the future trends and demands for the forecast period, 2024 -   2033        . The report covers the estimation of key market players, emerging new players, and regional analysis to offer a better understanding of the Computerized Physician Order Entry CPOE Market .   Furthermore, the report is updated with the changes in the market dynamics and economic scenario due to the COVID-19 pandemic. The report assesses the impact of the pandemic on the overall market and provides a detailed assessment of the present and future impact of the COVID-19 pandemic on the industry. The Computerized Physician Order Entry (CPOE) Market is expected to grow from an estimated USD 1,965.5 million in 2024 to USD 3,674.7 million in 2033, at a CAGR of 7.2%.The increasing need for better patient safety is fueling the expansion of the computerized ph...